A message board observation;
Honeycomb and Healthywelth and are a bit too optimistic. A couple of key points is that INNV can't be compared to a GSK for a variety or reasons, nutra vs.pharma, etc. INNV can't be compared to some of the other smaller companies, because Honey didn't take into account the reverse splits. Damaj hasn't lost any money on INNV stock per say, because it's only a paper loss and not an actual realized loss, plus Damaj is an INNV creditor and has been paying himself interest.
Honeycomb and Healthywelth are not entirely wrong though and it's good to be positive, but it's just not good to be overly optimistic.
ShawnP123 and TrueTrades are a bit too negative, but they do make several realstic points that we and Honeycomb and Healthywelth need to take into account, such as; INNV can't be compared to some of the other smaller companies, because Honey didn't take into account the reverse splits. Damaj hasn't lost any money on INNV stock per say, because it's only a paper loss and not an actual realized loss, plus Damaj is an INNV creditor and has been paying himself interest.
An accurate assesment of INNV is really a combination of what Honeycomb, Healthywelth, Shawn and Truetrades have posted.
This is not meant to discount other posters that have contributed valid points.
